carbonthatcarbonthat
← Every company

Who Owns Neurocrine Biosciences Inc

Every manager with more than $100m in listed equities files a 13F each quarter naming what they hold. These are the ones reporting a position in Neurocrine Biosciences Inc.

Who crossed 5% of NBIX →
Managers holding
22
as of 2026-09-30
Reported value
$50.6M
summed across filings
Shares held
357K
Added vs trimmed
9 / 5
since each filer's last quarter

Positions as of 2026-09-30

Largest first. The move is against the previous quarter that manager filed, not the previous calendar quarter.

ManagerValue
PKO BP BANKOWY Universal Pension Society JSCCOM170.8K shheld$24.2M
CONGRESS ASSET MANAGEMENT COCOM120.8K shadded$17.1M
ARGENT CAPITAL MANAGEMENT LLCCOM17.4K shtrimmed$2.5M
Red Spruce Capital, LLCCOM16.8K shadded$2.4M
MOODY NATIONAL BANK TRUST DIVISIONCOM6.2K sh—$873.2K
JUNCTURE WEALTH STRATEGIES, LLCCOM5.3K shadded$752.7K
GAMMA Investing LLCCommon Stock3.9K shadded$547.2K
Whalen Wealth Management Inc.COM3.7K shtrimmed$525.6K
Farther Finance Advisors, LLCStock3.4K shadded$487.6K
City Center Advisors, LLCCOM2K shtrimmed$285.1K
Wedmont Private CapitalCOM1.9K shadded$273.5K
Valeo Financial Advisors, LLCStock1.7K shadded$240.6K
Central Pacific Bank - Trust DivisionCOM1.7K shheld$237.6K
CoreCap Advisors, LLCStock565 shadded$80.1K
GK Wealth Management LLCCOM427 sh—$60.6K
MassMutual Private Wealth & Trust, FSBCommon / Ordinary Stock365 shtrimmed$51.8K
MJT & Associates Financial Advisory Group, Inc.Stock33 shadded$4.7K
Retirement Wealth Solutions LLCCOM32 shtrimmed$4.5K
ELEVATION WEALTH PARTNERS, LLCCOM14 shheld$2K
Marquette Asset Management, LLCCOM11 shheld$1.6K
ATWOOD & PALMER INCCOM5 shheld$710
Trust CoStock3 shheld$426

Source: quarterly 13F filings, via EDGAR. A 13F reports positions by CUSIP alone; each CUSIP here has been confirmed against OpenFIGI rather than matched by name, because a name match would attribute one company's shareholders to another. Positions are as of quarter end and can be months old by the time they are filed, and 13F covers long equity positions only — not shorts, and not most debt. The summed value is what these filers reported, not the company's institutional ownership.

More on NBIX

Company overviewEverything on NBIX in one place, with the price.SEC filingsWhat NBIX's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat NBIX's own officers and directors buy and sell.Planned salesSales NBIX insiders have filed notice of.Executive payWhat NBIX awarded its chief executive, and what it became.Funds holding itWhich funds and ETFs hold NBIX, and how big a bet.LobbyingWhat NBIX spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on NBIX's account, and who they worked for.PatentsWhat NBIX is filing at the patent office.

Follow Neurocrine Biosciences Inc (NBIX) by email

New trades in Neurocrine Biosciences Inc (NBIX) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

Whale MovesAnyone crossing five per cent, and whether they want a say.SectorsEvery company by sector and industry, with valuations.Stock ScreensPiotroski, Graham, dividend records and most shorted.Fund Manager CommentaryWhat well-known funds' managers say drove their year.